INS 316

DB05390ExperimentalSmall molecule

INS316 belongs to the family of drugs called nucleoside triphosphates.It is studied in the diagnosis of lung diseases, including lung cancer. It is selective P2y2 receptor antagonists claimed to be...

Mechanism: INS316 helps to bring up a sample of mucus from deep in the lungs and improves the quality of the sample for testing.
Curator reviewed
Primary indication: Investigated for use/treatment in lung cancer.Curator reviewed
Code names: INS 316

Resolves to

Targets

P51582P2RY4Q96G91P2RY11Q15077P2RY6P41231P2RY2

What you can answer from here — as of April 02, 2025

4Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with INS 316, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account